Navigation Links
Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
Date:11/7/2007

BETHESDA, Md. Nov. 7 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), an independent American provider of Western healthcare services and products in the People's Republic of China, today announced profitable results for the quarter and six months ended September 30, 2007, including a 86% increase and a 76% increase respectively, in net income.

Revenue for the quarter ended September 30, 2007 was $32.7 million, a 23% increase over revenue of $26.5 million in the quarter ended September 30, 2006. Net income from continuing operations for the quarter ended September 30, 2007 was $1.6 million, or earnings per basic share on continuing operations of $0.22. This compares to a net income from continuing operations of $1.1 million, or earnings per basic share on continuing operations of $0.17 for the quarter ended September 30, 2006.

Revenue for the six months ended September 30, 2007 was $59.4 million, a 17% increase over revenue of $50.9 million in the six months ended September 30, 2006. Net income from continuing operations for the six months ended September 30, 2007 was $2.4 million, or earnings per basic share on continuing operations of $0.33. This compares to a net income from continuing operations of $1.7 million, or earnings per basic share on continuing operations of $0.25 for the six months ended September 30, 2006.

The Company's balance sheet as of September 30, 2007 shows cash, cash equivalents and restricted cash of $14.3 million, total assets of $67.7 million, a current ratio of 1.8:1 and stockholders' equity of $32.3 million.

Roberta Lipson, Chindex CEO commented on the results for the quarter: "Our continuing bottom line performance on a consolidated basis this quarter was again led by an increase in the profitability of our Healthcare Services division. This was fueled by continued growth in inpatient and outpatient results in both the Beijing and Shanghai markets. Our development program for new United Family Healthcare facilities in Guangzhou and Beijing is entering a new phase. We are currently implementing our market entry program in Guangzhou with the commencement of construction of an outpatient clinic center, which will precede our main hospital facility development program. We are proceeding with plans for a second hospital in Beijing as well as active participation in a variety of programs related the Olympics to be held in Beijing next summer."

"The Medical Products division reported profitable results for the quarter due to strong performance in imaging and surgical product categories. The market issues which have been impacting us over the past several quarters have not abated completely, however the pent up demand for imported medical devices which has been accumulating over the past two years is driving sales throughout the country now. Our outlook for the Medical Products division continues to be optimistic. We believe the conditions are aligned for continuing good performance in this division in the future."

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing and Shanghai metropolitan areas. The Company sells medical products manufactured by various major multinational companies, including Siemens AG, which is the Company's exclusive distribution partner for the sale and servicing of color doppler ultrasound systems. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-six years of experience, 1,000 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, http://www.chindex.com and http://www.unitedfamilyhospitals.com .

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in our annual report on Form 10-K for the year ended March 31, 2007, updates and additions to those "Risk Factors" in our interim reports on Form 10-Q and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may", "will", "should", "could", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "forecasts", "potential", or "continue" or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We have no obligation to update these forward- looking statements. CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (thousands except share and per share data) (Unaudited)

Three months ended Six months ended

September 30, September 30,

2007 2006 2007 2006

Product sales $17,550 $15,686 $28,762 $28,487

Healthcare services revenue 15,102 10,794 30,661 22,407

Total revenue 32,652 26,480 59,423 50,894

Cost and expenses

Product sales costs 12,916 12,048 21,285 21,248

Healthcare services costs 12,106 9,529 23,970 18,997

Selling and marketing

expenses 2,782 2,334 5,466 4,587

General and administrative

expenses 2,233 1,688 4,723 3,530

Income from continuing

operations 2,615 881 3,979 2,532

Other (expenses) and income

Interest expense (187) (199) (374) (386)

Interest income 74 60 141 124

Miscellaneous(expense)

income - net (21) 20 (47) 5

Income from continuing

operations before income

taxes 2,481 762 3,699 2,275

(Provision for) benefit from

income taxes (843) 368 (1,251) (619)

Net income from continuing

operations 1,638 1,130 2,448 1,656

Loss from discontinued

operations 0 (251) (0) (264)

Net income $1,638 $879 $2,448 $1,392

Net income per common share -

basic

Continuing operations $0.22 $0.17 $0.33 $0.25

Discontinued operations (0.00) (0.04) (0.00) (0.04)

Net income $0.22 $0.13 $0.33 $0.21

Weighted average shares

outstanding - basic 7,442,013 6,753,902 7,333,142 6,741,197

Net income per common share -

diluted

Continuing operations $0.21 $0.15 $0.31 $0.22

Discontinued operations (0.00) (0.03) (0.00) (0.04)

Net income $0.21 $0.12 $0.31 $0.18

Weighted average shares

outstanding - diluted 7,958,650 7,557,288 7,850,832 7,535,027 CONSOLIDATED CONDENSED BALANCE SHEETS (thousands except share data)

September 30, 2007 March 31, 2007

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents $12,655 $9,106

Restricted cash 1,689 1,590

Trade accounts receivable, less

allowance for doubtful accounts

of $3,585 and $2,827,

respectively

Product sales

receivables 12,634 13,133

Patient service

receivables 6,685 6,104

Inventories 9,609 7,835

Deferred income taxes 2,495 2,463

Other current assets 3,343 3,153

Total current assets 49,110 43,384

Property and equipment, net 17,551 18,482

Long-term deferred income taxes 601 607

Other assets 463 434

Total assets $67,725 $62,907

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable and accrued expenses $22,720 $22,877

Short-term portion of capitalized

leases 33 36

Short-term debt and vendor financing 3,124 2,710

Income taxes payable 780 629

Total current liabilities 26,657 26,252

Long-term portion of capitalized

leases 41 58

Long-term debt and vendor financing 8,776 8,679

Total liabilities 35,474 34,989

Commitments and contingencies

Stockholders' equity:

Preferred stock, $.01 par value,

500,000 shares authorized, none

issued 0 0

Common stock, $.01 par value,

28,200,000 shares authorized,

including 3,200,000 designated

Class B:

Common stock - 6,685,043 and

6,332,345 shares issued and

outstanding at September 30, 2007

and March 31, 2007, respectively 67 63

Class B stock - 775,000 shares issued

and outstanding at September 30,

2007 and March 31, 2007,

respectively 8 8

Additional paid in capital 40,819 38,947

Accumulated other comprehensive

income 115 106

Accumulated deficit (8,758) (11,206)

Total stockholders' equity 32,251 27,918

Total liabilities and stockholders'

equity $67,725 $62,907

SEGMENT INFORMATION

The Company operates in two businesses: Healthcare Services and Medical Products. The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes, not including foreign exchange gains or losses. The following segment information has been provided per Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information:"

Healthcare Medical

Services Products Total

As of September 30, 2007:

Assets $38,174,000 $29,551,000 $67,725,000

For the three months ended

September 30, 2007:

Sales and service revenue $15,102,000 $17,550,000 $32,652,000

Gross Profit n/a* 4,634,000 n/a

Gross Profit % n/a* 26% n/a

Income from continuing operations

before foreign exchange $2,040,000 $304,000 $2,344,000

Foreign exchange gain 271,000

Income from continuing operations $2,615,000

Other (expense), net (134,000)

Income from continuing operations

before income taxes $2,481,000

Healthcare Medical

Services Products Total

As of March 31, 2007:

Assets $34,129,000 $28,778,000 $62,907,000

For the three months ended

September 30, 2006:

Sales and service revenue $10,794,000 $15,686,000 $26,480,000

Gross Profit n/a* 3,638,000 n/a

Gross Profit % n/a* 23% n/a

Income from continuing operations

before foreign exchange $695,000 $83,000 $778,000

Foreign exchange loss 103,000

Income from continuing operations $881,000

Other(expense), net (119,000)

Income from continuing operations

before income taxes $762,000

Healthcare Medical

Services Products Total

As of September 30, 2007:

Assets $38,174,000 $29,551,000 $67,725,000

For the six months ended September

30, 2007:

Sales and service revenue $30,661,000 $28,762,000 59,423,000

Gross Profit n/a* 7,477,,000 n/a

Gross Profit % n/a* 26% n/a

Income (loss) from continuing

operations before foreign exchange $4,838,000 ($1,201,000) $3,637,000

Foreign exchange gain 342,000

Income from continuing operations $3,979,000

Other (expense), net (280,000)

Income from continuing operations

before income taxes $3,699,000

Healthcare Medical

Services Products Total

As of March 31, 2007:

Assets $34,129,000 $28,778,000 $62,907,000

For the six months ended September

30, 2006:

Sales and service revenue $22,407,000 $28,487,000 $50,894,000

Gross Profit n/a* 7,239,000 n/a

Gross Profit % n/a* 25% n/a

Income from continuing operations

before foreign exchange $2,282,000 $179,000 $2,461,000

Foreign exchange gain 71,000

Income from continuing operations $2,532,000

Other (expense), net (257,000)

Income from continuing operations

before income taxes $2,275,000

* Gross profit margins are not routinely calculated in the healthcare industry.

For more information, please contact:

Lawrence Pemble

Judy Zakreski

Chindex International, Inc.

Tel: +1-301-215-7777


'/>"/>
SOURCE Chindex International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
2. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
5. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: